Skip to content

Combined Oxidative Phosphorylation Defect Type 4 C1857682

Published: July 22, 2026Updated: August 20, 2026

A rare mitochondrial disorder affecting the body's energy production at the cellular level. Can cause problems with muscles, nerves, brain, and heart. Treatment focuses on managing specific symptoms and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Lactic acidosis

(metabolic)

Muscle weakness

(metabolic)

Cardiomyopathy

(metabolic)

Sensorineural hearing loss

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Coenzyme Q10 Supplementation

CoQ10 serves as an electron carrier in the mitochondrial electron transport chain. Supplementation may improve ATP production in patients with oxidative phosphorylation defects.

medication
2

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

L-Carnitine Supplementation

Carnitine facilitates fatty acid transport into mitochondria for energy production. Supplementation helps compensate for impaired oxidative phosphorylation in muscle and cardiac tissue.

medication

Additional treatment options

Mitochondrial-Friendly Diet

A diet rich in easily metabolized carbohydrates and moderate protein, with careful fat restriction, supports mitochondrial function. Small, frequent meals may help maintain energy levels.

dietary

Riboflavin B2 Supplementation

Riboflavin is a precursor to FAD, a critical cofactor in mitochondrial complex I and II. High-dose supplementation may improve electron transport chain function.

complementary

Multisystem Function Monitoring

Regular cardiac, hepatic, and neurological assessments detect organ-specific mitochondrial dysfunction. Lactate levels and metabolic screening guide disease management.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Combined Oxidative Phosphorylation Defect Type 4 C1857682?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Parikh S, Goldstein A, Karaa A, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2017.

guideline2017View source →
2

Suomalainen A, Battersby BJ. Mitochondrial diseases: towards mechanistic therapies. Nat Rev Drug Discov. 2018.

review2018View source →
3

Houghton BC, Uittenbogaard M, Li FY, et al. Novel approaches to treating combined oxidative phosphorylation defects: a phase I/II trial of rapamycin in children with mitochondrial disease. Ann Neurol. 2021.

clinical_trial2021View source →
4

Gorman GS, Chinnery PF, DiMauro S, et al. Mitochondrial diseases. Nat Rev Dis Primers. 2016.

review2016View source →

Medication Comparisons

Compare medications used to treat Combined Oxidative Phosphorylation Defect Type 4 C1857682. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy